Wird geladen...
RTHP-23. ADJUVANT THERAPY FOR HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA AFTER RTOG 9802: A SURVEY OF CURRENT PRACTICE
PURPOSE: RTOG 9802 long-term results (NEJM, April 2016) demonstrated significant improvements in overall survival with chemoradiotherapy (CRT) compared to radiotherapy alone, for patients with low-grade, high-risk supratentorial oligodendroglioma. Before publication of RTOG 9802, many such patients...
Gespeichert in:
| Veröffentlicht in: | Neuro Oncol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692294/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.906 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|